Futu News, June 10, this Friday $MEGA GENOMICS (06667.HK)$The announcement was announced that the shares will be offered from June 10 to 15. The company plans to issue 11.9618 million shares, including a public sale of 1.1962 million shares and an international sale of 10.765,600 shares, with an issue price of HK$18-22 per share and 200 shares per lot. It is expected to be listed on June 22.
Meiyin Gene is a leading genetic testing platform company in China, focusing on consumer-grade genetic testing and cancer screening services. According to Frost & Sullivan, the company is the largest consumer-grade genetic testing platform in China. Based on the number of tests carried out in 2020, the company's market share exceeds 60%, and the number of tests carried out is more than ten times that of the second largest. In terms of revenue for the same year, the company's market share was 34.2%, ranking first in China, greater than the sum of the second to sixth places.
As of December 31, 2021, since the company was founded in 2016, the company has carried out more than 12 million genetic tests, with an average of more than 246,000 tests per month in 2021.
The company's consumer-grade genetic testing services provide a full range of genetic testing services, covering various fields of expertise, including nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The company's testing services help consumers understand their unique physical characteristics and make better decisions about their lifestyle, diet, and medication. The company...